Table 3 Only SMARTREAB desaturators and both desaturators compared.
Group C | Group D | Difference of means or medians* | 95% CI | P-value | |
|---|---|---|---|---|---|
N = 27 | N = 64 | ||||
Age (years; mean ± SD) | 62.8 ± 12.0 | 67.7 ± 8.1 | − 4.8 ± 2.2 | − 9.1 to − 0.5 | 0.028** |
Pulmonary function | |||||
FVC pred (%; mean ± SD) | 94.7 ± 19.9 | 73.7 ± 25.4 | 21.1 ± 5.0 | 11.1 to 31.0 | < 0.0005** |
DLCO pred (%; mean ± SD) | 71.0 ± 23.8 | 49.7 ± 22.2 | 21.2 ± 5.9 | 9.2 to 33.2 | 0.001** |
6MWT | |||||
6MWD (m; mean ± SD) | 375.6 ± 121.6 | 296.5 ± 103.8 | 79.1 ± 26.8 | 25.1 to 133.0 | 0.005** |
Nadir SpO2 (%; mean ± SD) | 92.4 ± 1.8 | 83.1 ± 5.4 | 9.3 ± 1.1 | 7.2 to 11.4 | < 0.0005** |
Peak HR (%; mean ± SD) | 67.2 ± 10.6 | 72.9 ± 12.4 | − 5.7 ± 2.6 | − 10.8 to − 0.6 | 0.030** |
Activity intensity (MET; mean ± SD) | 2.8 ± 0.6 | 2.4 ± 0.5 | 0.4 ± 0.1 | 0.1 to 0.6 | 0.005** |
Number of pauses (n; median, IQR) | 0 (0–0) | 0 (0–1) | − 2.5 | – | 0.016*** |
Number of periods SpO2 < 90% (n; median, IQR) | 0 (0–0) | 1 (1–2) | − 8.1 | – | < 0.0005*** |
SMARTREAB telemonitoring | |||||
Nadir SpO2 (%; mean ± SD) | 80.3 ± 5.8 | 76.5 ± 7.6 | 3.8 ± 1.5 | 0.9 to 6.7 | 0.011** |
Peak HR (%; mean ± SD) | 80.5 ± 11.3 | 80.2 ± 11.4 | 0.3 ± 2.6 | − 4.9 to 5.5 | 0.905** |
Activity intensity (MET; mean ± SD) | 3.1 ± 0.7 | 2.8 ± 0.6 | 0.3 ± 0.2 | 0.0 to 0.6 | 0.069** |
Daily episodes SpO2 < 90% (n; median, IQR) | 2 (1–5) | 9 (5–17) | − 4.3 | – | < 0.0005*** |
Longest period SpO2 < 90% (min; mean ± SD) | 25.4 ± 41.8 | 32.8 ± 35.4 | − 7.4 ± 9.2 | − 26.0 to 11.1 | 0.424** |